ImmunityBio Faces Securities Fraud Class Action Lawsuit

Kessler Topaz Meltzer & Check, LLP has announced the filing of a securities fraud class action lawsuit against ImmunityBio, Inc.

29 Apr, 21:42 — 29 Apr, 21:42

Post Share

Sources

Showing 1 of 1 sources

globe-and-mailHigh109d ago

NASDAQ: IBRX: Kessler Topaz Meltzer & Check, LLP Announces the Filing of a Securities Fraud Class Action Lawsuit Against ImmunityBio, Inc. - The Globe and Mail

NASDAQ: IBRX: Kessler Topaz Meltzer & Check, LLP Announces the Filing of a Securities Fraud Class Action Lawsuit Against ImmunityBio, Inc. The Globe and Mail

Read full article →

PERSPECTA

PERSPECTA

ImmunityBio Faces Securities Fraud Class Action Lawsuit

Sources

NASDAQ: IBRX: Kessler Topaz Meltzer & Check, LLP Announces the Filing of a Securities Fraud Class Action Lawsuit Against ImmunityBio, Inc. - The Globe and Mail

Related Stories

Bulgaria Returns 11.6 Tons of Peppers to North Macedonia Due to Pesticides

Goldman Sachs to Acquire ETF Provider Neos in $2.3 Billion Deal

L3Harris CEO Chris Kubasik Ousted Over Unspecified Conduct

KBR Secures $60 Million NATO Contract for Missile Defense System

PERSPECTA